CD Genomics introduces an enhanced ribosome profiling (enhanced Ribo-seq) workflow that isolates actively translating ribosomes for a clearer, more dynamic view of gene expression and protein synthesis.
This next-generation platform improves conventional Ribo-seq by delivering single-nucleotide precision, detecting alternative ORFs, and enabling low-input compatibility across human, mouse, and rat models.
Key Highlights:

Studies show that nearly 40% of ribosomes captured by standard Ribo-seq are stalled, leading to an underestimation of translation efficiency.
Conventional Ribo-seq measures all ribosomes bound to mRNA — both active and paused — reducing the accuracy of translation readouts.
CD Genomics' Enhanced Ribosome Profiling focuses only on actively translating ribosomes, improving translation efficiency accuracy and correlation with proteomics.
For a comparison with polysome-based methods, explore our Polysome Profiling Service.
| Feature | Enhanced Ribosome Profiling | Standard Ribo-seq |
|---|---|---|
| Target ribosomes | Actively translating ribosomes only | All ribosomes bound to mRNA (active + stalled) |
| Translation efficiency accuracy | High — directly tied to protein synthesis | Moderate — includes paused/stalled ribosomes |
| Input material requirement | Significantly reduced — supports low-input or small samples | Higher input required |
| Sensitivity | Detects low-abundance translation events, novel ORFs | May miss subtle or rare translational events |
| Workflow type | Tag- and antibody-free enrichment, streamlined protocol | Often requires gradient fractionation or large volumes |
| Proteomics correlation | Stronger match with protein output | Weaker correlation due to mixed ribosome states |
| Compatible sample types | Bulk, low-input, potentially single-cell | Typically bulk only |
| Ideal for applications | Translational regulation, drug response, novel peptide discovery | Global ribosome occupancy, broader translation load studies |
Our enhanced ribosome profiling workflow isolates ribosomes engaged in active peptide elongation, accurately depicting the translation landscape at single-gene and codon levels.
Optimized chemistry and streamlined sequencing preparation enable reliable results from minimal input, making it ideal for rare tissues, primary cells, or precious clinical research samples.
Achieve codon-level mapping of ribosome footprints to uncover translation start sites, elongation dynamics, and frame-specific activity with unmatched accuracy.
These technical advantages allow researchers to monitor translation efficiency and protein synthesis more precisely than with standard ribosome profiling or polysome-based methods.
We follow a refined ribosome profiling workflow designed for precision and reproducibility.
| Analysis Type | Content Description |
|---|---|
| Active Ribosome Profiling (Ribo-seq) | |
| 1. Genome-wide translational activity profiling | Identify actively translating regions and ribosome density across all transcripts. |
| 2. Gene-level translation efficiency (TE) calculation | Compute TE by normalising ribosome footprints to RNA abundance. |
| 3. Differential TE gene analysis | Detect genes showing significant shifts in translational efficiency between groups. |
| 4. GO enrichment of differential TE genes | Reveal functional categories associated with translation-level regulation. |
| 5. KEGG pathway enrichment of differential TE genes | Highlight metabolic or signalling pathways influenced by translational control. |
| 6. Start codon prediction (including non-ATG initiation) | Detect canonical and non-canonical translation initiation sites. |
| 7. ORF (open reading frame) prediction | Map precise ORF boundaries and identify alternative coding frames. |
| 8. Novel protein and micropeptide identification | Discover small peptides and unannotated coding sequences from ribosome footprints. |
| 9. Codon usage and frequency analysis | Evaluate codon bias and its impact on translational efficiency. |
| 10. lncRNA / circRNA coding potential prediction | Assess ribosome association with non-coding RNAs to identify potential translation events. |
| longRNA-seq (Transcriptome Control Dataset) | |
| 1. Data quality control (QC) | Evaluate sequencing depth, base quality, and read distribution. |
| 2. Read alignment and quantification | Map reads to reference genomes and quantify expression levels. |
| 3. mRNA differential expression analysis | Identify transcriptional changes between experimental conditions. |
| 4. lncRNA differential expression analysis | Characterise long non-coding RNA expression trends. |
| 5. GO enrichment of differential genes | Annotate biological processes altered at the transcriptional level. |
| 6. KEGG enrichment of differential genes | Reveal pathways regulated at the mRNA stage. |
| 7. circRNA differential expression analysis | Detect and quantify circular RNA expression changes. |
We combine ribosome profiling (Ribo-seq) data with RNA-seq datasets to calculate translation efficiency (TE), predict ORFs and novel peptides, and uncover translational control mechanisms across conditions.
This integrated analysis links transcription and translation, helping researchers interpret gene regulation with greater biological accuracy.
Understanding gene expression requires studying not only transcription but also translation — the final step that defines protein output. Traditional RNA-seq measures transcript abundance, yet protein levels often diverge from mRNA expression. Our Enhanced Ribosome Profiling workflow captures this missing layer by directly quantifying translational activity through ribosome-protected fragments.
By combining translational profiling and longRNA-seq, researchers can correlate RNA abundance with translation efficiency. This dual-omics design distinguishes whether changes in protein production arise from transcriptional or translational regulation.
When RNA–protein correlation is poor
Translational profiling pinpoints post-transcriptional regulation and identifies transcripts that are ribosome-bound but translationally silent.
When differential expression lists are extensive
Integrating translation data refines target selection, highlighting genes whose ribosome occupancy truly changes rather than those affected by transcriptional noise.
When validating expression patterns
Co-expression and clustering analyses between translation efficiency and RNA expression reveal consistent regulatory modules, guiding downstream validation or functional studies.
This workflow delivers a complete view of the transcriptome-to-proteome continuum, enabling more accurate biological interpretation in areas such as functional genomics, drug response studies, and agricultural trait development.
Pairing ribosome profiling (Ribo-seq) with longRNA-seq links translation to transcriptional context. This joint design improves biological interpretation and strengthens downstream decision-making.
Define ribosome occupancy along each transcript at single-base resolution, separating active from stalled complexes for reliable translation efficiency readouts.
Detect canonical and non-canonical initiation, upstream ORFs, and alternative coding frames missed by expression-only assays.
Compute TE by normalising footprints to matched RNA abundance, enabling robust ribosome profiling data analysis across conditions.
Distinguish transcription-driven shifts from true translational control when Ribo-seq and RNA-seq trends diverge.
Reveal translated sORFs within presumed non-coding RNAs, guiding target validation and proteomics follow-up.
| Sample Type | Minimum Requirement | Notes |
|---|---|---|
| Cell samples | ≥ 1 × 10⁶ cells / sample | Cultured or primary cells |
| Tissue samples | ≥ 50 mg / sample | Flash-frozen without preservatives |
| Supported species | Human, Mouse, Rat | Other species upon consultation |
Experimental Design:
Our Enhanced Ribosome Profiling service provides publication-ready data illustrating active translation dynamics across the genome. Below are representative outputs from internal validation experiments.
Figure 1. Read-length distribution of ribosome footprints
Ribosome-protected fragments (RPFs) cluster predominantly between 28–32 nt, reflecting genuine ribosome footprints and confirming high data quality.
Figure 2. P-site signal distribution across transcript regions
The majority of P-site signals are enriched in coding sequences (CDS), with minor presence in 5′-UTRs and 3′-UTRs, consistent with active protein synthesis.
Figure 3. Three-nucleotide periodicity pattern
Footprint density exhibits a clear 3-nt periodicity along coding regions—an established hallmark of active elongating ribosomes.
Figure 4. Codon usage frequency comparison
Differential codon usage between control and treatment samples reveals changes in translational efficiency and tRNA adaptation under varying conditions.
Ribosome Footprint Integrity
Short protected fragments (~28–32 nt) confirm authentic ribosome-bound RNA and high data precision.
Active Translation Region Mapping
P-site enrichment within CDS demonstrates active translation and correct frame assignment.
High-Fidelity Periodicity Signal
Clear 3-nt periodicity validates codon-level resolution, ensuring accurate translation efficiency analysis.
Codon Usage and Translational Bias
Differences in codon usage reflect dynamic adaptation of tRNA pools and condition-specific translational control.
References: